About Phenox
Phenox is a Healthcare company based in Bochum (Germany) founded in 2005, and was acquired by Wallaby Medical in April 2022. Developer of medical devices for interventional neurology. Phenox offers products and services including HPC Coating, pRESET, and Flow Diverter. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is phenox GmbH.
Company details
Phenox was founded in 2005 and is based in Bochum, Germany. Medical devices for interventional neurology are developed by the company, focusing on treatments for aneurysms and acute ischemic stroke. Key products include the p64 flow modulation device, pCONus bifurcation aneurysm implant for wide-neck aneurysms, pREset LITE thrombectomy device, and pITA rapid exchange neurovascular PTA balloon catheter. Operations center on innovation in neurovascular interventions.
- Headquarters Bochum, Germany
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website phenox.net/international
- Social LinkedIn X YouTube
- Acquired by Wallaby Medical (Apr 2022)
- Legal Name Phenox Gmbh
- InvestorsNRW.Bank
& 2 more
- Acquired byWallaby Medical
(Apr 2022)
Products & Services of Phenox
Phenox offers a comprehensive portfolio of products and services, including HPC Coating, pRESET, and Flow Diverter.
Hydrophilic polymer that reduces thrombosis on implants.
Device for ischemic stroke management.
Implant to treat aneurysms with reduced thrombosis risk.
Apps and channels of Phenox
its YouTube channel phenox GmbH has 458 subscribers.
Funding Insights of Phenox
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Phenox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Phenox
Phenox has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, Wallaby Medical and SHS Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare-focused private equity investments are managed by SHS Capital. | 1993 | shs-capital.eu | Tübingen, Germany | |
Loans, advice, seminars, and networks are provided for financial support. | 2001 | nrwbank.de | Dusseldorf, Germany | |
A medical device for stroke treatment is developed. | 2016 | wallabymedical.com | Laguna Hills, United States |
Investor details for Phenox
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Phenox
4 dated milestones of Phenox across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Phenox is founded.
- Funding First funding round.
- Funding Latest funding round, Series A,.
- Exit Acquired by Wallaby Medical.
Web traffic of Phenox
The website of Phenox (phenox.net) receives about 6.4K visits a month.
- Monthly visits6.4K
▲ 156.9% vs previous month
Websites whose visitors overlap most with Phenox. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medecon.ruhr | medecon.ruhr | 100% | #2,824,852 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phenox
Complete news archive for Phenox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phenox
Phenox was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Phenox is headquartered in Bochum, Germany. It is registered at Bochum, North Rhine-westphalia, Germany.
Phenox was founded in 2005 and is based in Bochum, Germany. Medical devices for interventional neurology are developed by the company, focusing on treatments for aneurysms and acute ischemic stroke. Key products include the p64 flow modulation device, pCONus bifurcation aneurysm implant for wide-neck aneurysms, pREset LITE thrombectomy device, and pITA rapid exchange neurovascular PTA balloon catheter. Operations center on innovation in neurovascular interventions.
Phenox offers HPC Coating, pRESET, and Flow Diverter.
Phenox has 3 investors. Key investors include NRW.Bank, Wallaby Medical, and SHS Capital.
Phenox operates through Phenox Gmbh.
Yes. Phenox was acquired by Wallaby Medical in April 2022.

